FDA Inspection Finds Numerous Problems At Facility Intended To Make J&J Vaccine
The report on Emergent BioSolutions’ Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.
(Image credit: Tasos Katopodis/Getty Images)
